IMPROVE Study Phase 2

Data to Support Drug Product Communications as Used by the FDA

OMB: 0910-0695

IC ID: 224206

Information Collection (IC) Details

View Information Collection (IC)

IMPROVE Study Phase 2 CDER
 
Unchanged
 
Voluntary
 

Document Type Form No. Form Name Instrument File URL Available Electronically? Can Be Submitted Electronically? Electronic Capability
Other-IMPROVE Survey Instrument FDA IMPROVE SURVEY.pdf Yes Yes Fillable Fileable
Other-IMPROVE Survey Screener FDA IMPROVE Screener.pdf Yes Yes Fillable Fileable

Health Consumer Health and Safety

 

850 0
   
Individuals or Households
 
   100 %

  Requested Program Change Due to New Statute Program Change Due to Agency Discretion Change Due to Adjustment in Agency Estimate Change Due to Potential Violation of the PRA Previously Approved
Annual Number of Responses for this IC 850 0 0 0 0 850
Annual IC Time Burden (Hours) 170 0 0 0 0 170
Annual IC Cost Burden (Dollars) 0 0 0 0 0 0

Title Document Date Uploaded
IMPROVE Study Phase 2 Supporting Statement FDA IMPROVE PHASE 2 SS.pdf 10/30/2016
Revised Screener FDA IMPROVE Screener Revised 12-19 tracked changes.pdf 01/19/2017
Revised Screener clean version FDA IMPROVE Screener Revised 12-19 clean.pdf 01/19/2017
Non Sub Request Memo re. Screener Revisions OMB Amendment Screener Memo 12-19.pdf 01/19/2017
            Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.

© 2024 OMB.report | Privacy Policy